Difference between revisions of "CD56"

Revision as of 17:37, 13 September 2014

CD56 is a commonly available immunostain that is seen in a number of tumours. It is a sensitive marker of neuroendocrine differentiation.

↑ Kurokawa, M.; Nabeshima, K.; Akiyama, Y.; Maeda, S.; Nishida, T.; Nakayama, F.; Amano, M.; Ogata, K. et al. (May 2003). "CD56: a useful marker for diagnosing Merkel cell carcinoma.". J Dermatol Sci 31 (3): 219-24. PMID 12727026.
↑ ^2.0 ^2.1 URL: http://www.nordiqc.org/Epitopes/CD56/CD56.htm. Accessed on: September 13, 2014.
↑ Bahrami, A.; Gown, AM.; Baird, GS.; Hicks, MJ.; Folpe, AL. (Jul 2008). "Aberrant expression of epithelial and neuroendocrine markers in alveolar rhabdomyosarcoma: a potentially serious diagnostic pitfall.". Mod Pathol 21 (7): 795-806. doi:10.1038/modpathol.2008.86. PMID 18487991.

Revision as of 17:36, 13 September 2014 (view source) Michael (talk \| contribs) ← Older edit		Revision as of 17:37, 13 September 2014 (view source) Michael (talk \| contribs) Newer edit →
Line 1:		Line 1:
	'''CD56''' is a commonly available [[immunostain]] that is seen in a number of tumours. It is a sensitive marker of neuroendocrine differentiation ~~and is considered [[neuroendocrine marker~~]].		'''CD56''' is a commonly available [[immunostain]] that is seen in a number of tumours. It is a sensitive [[neuroendocrine marker\|marker of neuroendocrine differentiation]].

	==Positive==		==Positive==